[1]
Yildiz, F. Phytoestrogens in Functional Foods. CRC Press; Taylor & Francis Ltd, 2005.
[2]
Slavin, J.L.; Lloyd, B. Health benefits of fruits and vegetables. Adv. Nutr., 2012, 3(4), 506-516.
[3]
Hashimoto, Y.; Hamaguchi, M.; Fukuda, T.; Ohbora, A.; Kojima, T.; Fukui, M. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. Endocrine, 2017, 57(1), 89-97.
[4]
Ballestri, S.; Nascimbeni, F.; Baldelli, E.; Marrazzo, A.; Romagnoli, D.; Lonardo, A. NAFLD as Sexual Dimorphic Disease: Role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv. Ther., 2017, 34(6), 1291-1326.
[5]
Gutierrez-Grobe, Y.; Ponciano-Rodríguez, G.; Ramos, M.H.; Uribe, M.; Méndez-Sánchez, N. Prevalence of non-alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann. Hepatol., 2010, 9(4), 402-409.
[6]
Bruno, S.; Maisonneuve, P.; Castellana, P.; Rotmensz, N.; Rossi, S.; Maggioni, M.; Persico, M.; Colombo, A.; Monasterolo, F.; Casadei-Giunchi, D.; Desiderio, F.; Stroffolini, T.; Sacchini, V.; Decensi, A.; Veronesi, U. Incidence and risk factors for nonalcoholic
steatohepatitis: Prospective study of 5408 women enrolled in
Italian tamoxifen chemoprevention trial. BMJ, 2005, 23, 330(7497), 932.
[7]
McKenzie, J.; Fisher, B.M.; Jaap, A.J.; Stanley, A.; Paterson, K.; Sattar, N. Effects of HRT on liver enzyme levels in women with type 2 diabetes: A randomized placebo-controlled trial. Clin. Endocrinol. (Oxf.), 2006, 65(1), 40-44.
[8]
Hamaguchi, M.; Kojima, T.; Ohbora, A.; Takeda, N.; Fukui, M.; Kato, T. Aging is arisk factor of nonalcoholic fatty liver disease in premenopausal women. World J. Gastroenterol., 2012, 18, 237-243.
[9]
Yang, J.D.; Abdelmalek, M.F.; Pang, H.; Guy, C.D.; Smith, A.D.; Diehl, A.M.; Suzuki, A. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology, 2014, 59, 1406-1414.
[10]
Yoneda, M.; Thomas, E.; Sumida, Y.; Schiffet, E.R. The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease. Hepatology, 2014, 60, 1792.
[11]
Luo, F.; Ishigami, M.; Achiwa, K.; Ishizu, Y.; Kuzuya, T.; Honda, T.; Hayashi, K.; Ishikawa, T.; Katano, Y.; Gotoet, H. Raloxifene ameliorates liver fibrosis of nonalcoholic steatohepatitis induced by choline-deficient high-fat diet in ovariectomized mice. Dig. Dis. Sci., 2015, 60, 2730-2273.
[12]
McKenzie, J.; Fisher, B.M.; Jaap, A.J.; Stanley, A.; Paterson, K.; Sattar, N. Effects of HRT on liver enzyme levels in women with type 2 diabetes: A randomized placebo-controlled trial. Clin. Endocrinol. (Oxf.), 2006, 65, 40-44.
[13]
Clark, J.M.; Brancati, F.L.; Diehl, A.M. Nonalcoholic fatty liver disease. Gastroenterology, 2002, 122, 1649-1657.
[14]
Klair, J.S.; Yang, J.D.; Abdelmalek, M.F.; Guy, C. D.; Gill, R.M.; Yates, K.; Unalp-Arida, A.; Lavine, J.E.; Clark, J.M.; Diehl, A.M.; Suzuki, A. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology, 2016, 64, 85-91.
[15]
Yang, J.D.; Abdelmalek, M.F.; Guy, C.D.; Gill, R.M.; Lavine, J.E.; Yates, K.; Klair, J.; Terrault, N.A.; Clark, J.M.; Unalp-Arida, A.; Diehl, A.M.; Suzuki, A. Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis. Clin. Gastroenterol. Hepatol., 2017, 15, 127-131.
[16]
Villa, E. Role of estrogen in liver cancer. Womens Health (Lond), 2008, 4, 41-50.
[17]
Yang, D.; Hanna, D.L.; Usher, J.; LoCoco, J.; Chaudhari, P.; Lenz, H-J.; Setiawan, V.W.; El-Khoueiry, A. Impact of sex on the survival of patients with hepatocellular carcinoma: A surveillance, epidemiology, and end results analysis. Cancer, 2014, 120, 3707-3716.
[18]
Jung, J.H.; Kim, H.S. The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease. Food Chem. Toxicol., 2013, 60, 404-412.
[19]
Jeon, S.; Park, Y.J.; Kwon, Y.H. Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-/-) mice fed a high-fat diet. Mol. Nutr. Food Res., 2014, 58(4), 830-841.
[20]
Kim, J.H.; Kim, Y.J. Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice. Endocr. J., 2015, 62(6), 531-542.
[21]
Huang, C.; Qiao, X.; Dong, B. Neonatal exposure to genistein ameliorates high-fat diet-induced non-alcoholic steatohepatitis in rats. Br. J. Nutr., 2011, 106(1), 105-113.
[22]
Kim, M.H.; Park, J.S.; Jung, J.W.; Byun, K.W.; Kang, K.S.; Lee, Y.S. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Int. J. Obes. (Lond)., 2011, 35(8), 1019-1030.
[23]
Panneerselvam, S.; Packirisamy, R.M.; Bobby, Z.; Elizabeth Jacob, S.; Sridhar, M.G. Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity). J. Nutr. Biochem., 2016, 38, 57-69.
[24]
Park, H.S.; Hur, H.J.; Kim, S.H.; Park, S.J.; Hong, M.J.; Sung, M.J.; Kwon, D.Y.; Kim, M.S. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. Mol. Nutr. Food Res., 2016, 60(9), 1944-1955.
[25]
Hess, D.; Igal, R.A. Genistein downregulates de novo lipid synthesis and impairs cell proliferation in human lung cancer cells. Exp. Biol. Med. (Maywood), 2011, 236(6), 707-713.
[26]
Kim, M.H.; Park, J.S.; Jung, J.W.; Byun, K.W.; Kang, K.S.; Lee, Y.S. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Int. J. Obes. (Lond)., 2011, 35(8), 1019-1030.
[27]
Kay, H.Y.; Kim, W.D.; Hwang, S.J.; Choi, H.S.; Gilroy, R.K.; Wan, Y.J.; Kim, S.G. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding. Antioxid. Redox Signal., 2011, 15(8), 2135-2146.
[28]
Kim, Y.W.; Kim, Y.M.; Yang, Y.M.; Kim, T.H.; Hwang, S.J.; Lee, J.R.; Kim, S.C.; Kim, S.G. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis. Free Radic. Biol. Med., 2010, 48(4), 567-578.
[29]
Panneerselvam, S.; Packirisamy, R.M.; Bobby, Z.; Elizabeth Jacob, S.; Sridhar, M.G. Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity). J. Nutr. Biochem., 2016, 38, 57-69.
[30]
Mohamed Salih, S.; Nallasamy, P.; Muniyandi, P.; Periyasami, V. Carani Venkatraman. A Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance. J. Diabetes, 2009, 1(4), 278-287.
[31]
Jeon, S.; Park, Y.J.; Kwon, Y.H. Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-/-) mice fed a high-fat diet. Mol. Nutr. Food Res., 2014, 58(4), 830-841.
[32]
Kim, M.H.; Kang, K.S.; Lee, Y.S. The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. Br. J. Nutr., 2010, 104(9), 1333-1342.
[33]
Gao, X.; van der Veen, J.N.; Hermansson, M.; Ordoñez, M.; Gomez-Muñoz, A.; Vance, D.E.; Jacobs, R.L. Decreased lipogenesis in white adipose tissue contributes to the resistance to high fat diet-induced obesity in phosphatidylethanolamine N-methyltransferase-deficient mice. Biochim. Biophys. Acta, 2015, 1851(2), 152-162.
[34]
Miller, C.N.; Yang, J.Y.; Avra, T.; Ambati, S.; Della-Fera, M.A.; Rayalam, S.; Baile, C.A. A dietary phytochemical blend prevents liver damage associated with adipose tissuemobilization in ovariectomized rats. Obesity (Silver Spring), 2015, 23(1), 112-119.
[35]
Park, H.S.; Hur, H.J.; Kim, S.H.; Park, S.J.; Hong, M.J.; Sung, M.J.; Kwon, D.Y.; Kim, M.S. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. Mol. Nutr. Food Res., 2016, 60(9), 1944-1955.
[36]
Jeon, S.; Park, Y.J.; Kwon, Y.H. Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-/-) mice fed a high-fat diet. Mol. Nutr. Food Res., 2014, 58(4), 830-841.
[37]
Ji, G.; Yang, Q.; Hao, J.; Guo, L.; Chen, X.; Hu, J.; Leng, L.; Jiang, Z. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms. Int. Immunopharmacol., 2011, 11(6), 762-768.
[38]
Park, Y.J.; Jang, Y.M.; Kwon, Y.H. Isoflavones prevent endoplasmic reticulum stress-mediated neuronal degeneration by inhibiting tau hyperphosphorylation in SH-SY5Y cells. J. Med. Food, 2009, 12(3), 528-535.
[39]
Anhê, F.F.; Roy, D.; Pilon, G.; Dudonné, S.; Matamoros, S.; Varin, T.V.; Garofalo, C.; Moine, Q.; Desjardins, Y.; Levy, E.; Marette, A. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut, 2015, 64(6), 872-883.
[40]
Ohtomo, T.; Uehara, M.; Peñalvo, J.L.; Adlercreutz, H.; Katsumata, S.; Suzuki, K.; Takeda, K.; Masuyama, R.; Ishimi, Y. Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures. Eur. J. Nutr., 2008, 47(5), 273-279.
[41]
Nakatsu, C.H.; Armstrong, A.; Clavijo, A.P.; Martin, B.R.; Barnes, S.; Weaver, C.M. Fecal bacterial community changes associated with isoflavone metabolites in postmenopausal women after soy bar consumption. PLoS One, 2014, 9(10), e108924
[42]
Hong, S.W.; Choi, J.Y.; Chung, K.S. Culture-based and denaturing gradient gel electrophoresis analysis of the bacterial community from Chungkookjang, a traditional Korean fermented soybean food. J. Food Sci., 2012, 77(10), M572-M578.
[43]
Frankenfeld, C.L.; Atkinson, C.; Wähälä, K.; Lampe, J.W. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein. Eur. J. Clin. Nutr., 2014, 68(4), 526-530.
[44]
Madak-Erdogan, Z.; Gong, P.; Zhao, Y.C.; Xu, L.; Wrobel, K.U.; Hartman, J.A.; Wang, M.; Cam, A.; Iwaniec, U.T.; Turner, R.T.; Twaddle, N.C.; Doerge, D.R.; Khan, I.A.; Katzenellenbogen, J.A.; Katzenellenbogen, B.S.; Helferich, W.G. Dietary licorice root supplementation reduces diet-induced weight gain, lipid deposition, and hepatic steatosis in ovariectomized mice without stimulating reproductive tissues and mammary gland. Mol. Nutr. Food Res., 2016, 60(2), 369-380.
[45]
Chen, K.L.; Madak-Erdogan, Z. Estrogen and Microbiota Crosstalk: Should We Pay Attention? Trends Endocrinol. Metab., 2016, 27(11), 752-755.